These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Design, synthesis, and anti-integrase activity of catechol-DKA hybrids. Maurin C; Bailly F; Mbemba G; Mouscadet JF; Cotelle P Bioorg Med Chem; 2006 May; 14(9):2978-84. PubMed ID: 16412645 [TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of novel N-hydroxy-dihydronaphthyridinones as potent and orally bioavailable HIV-1 integrase inhibitors. Johnson TW; Tanis SP; Butler SL; Dalvie D; Delisle DM; Dress KR; Flahive EJ; Hu Q; Kuehler JE; Kuki A; Liu W; McClellan GA; Peng Q; Plewe MB; Richardson PF; Smith GL; Solowiej J; Tran KT; Wang H; Yu X; Zhang J; Zhu H J Med Chem; 2011 May; 54(9):3393-417. PubMed ID: 21446745 [TBL] [Abstract][Full Text] [Related]
30. Caffeoylglycolic and caffeoylamino acid derivatives, halfmers of L-chicoric acid, as new HIV-1 integrase inhibitors. Lee SU; Shin CG; Lee CK; Lee YS Eur J Med Chem; 2007 Oct; 42(10):1309-15. PubMed ID: 17434650 [TBL] [Abstract][Full Text] [Related]
31. Discovery of potent HIV integrase inhibitors active against raltegravir resistant viruses. Le G; Vandegraaff N; Rhodes DI; Jones ED; Coates JA; Lu L; Li X; Yu C; Feng X; Deadman JJ Bioorg Med Chem Lett; 2010 Sep; 20(17):5013-8. PubMed ID: 20685117 [TBL] [Abstract][Full Text] [Related]
34. Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme. Li HY; Zawahir Z; Song LD; Long YQ; Neamati N J Med Chem; 2006 Jul; 49(15):4477-86. PubMed ID: 16854053 [TBL] [Abstract][Full Text] [Related]
35. Tricyclic HIV integrase inhibitors V. SAR studies on the benzyl moiety. Jin H; Metobo S; Jabri S; Mish M; Lansdown R; Chen X; Tsiang M; Wright M; Kim CU Bioorg Med Chem Lett; 2009 Apr; 19(8):2263-5. PubMed ID: 19285389 [TBL] [Abstract][Full Text] [Related]
36. Styrylquinazoline derivatives as HIV-1 integrase inhibitors. Lee JY; Park JH; Lee SJ; Park H; Lee YS Arch Pharm (Weinheim); 2002 Jun; 335(6):277-82. PubMed ID: 12210770 [TBL] [Abstract][Full Text] [Related]
37. 3-Hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidine-2-carboxylates--a new class of HIV-1 integrase inhibitors. Donghi M; Kinzel OD; Summa V Bioorg Med Chem Lett; 2009 Apr; 19(7):1930-4. PubMed ID: 19269170 [TBL] [Abstract][Full Text] [Related]
38. Ferrocenyl chalcone difluoridoborates inhibit HIV-1 integrase and display low activity towards cancer and endothelial cells. Monserrat JP; Al-Safi RI; Tiwari KN; Quentin L; Chabot GG; Vessières A; Jaouen G; Neamati N; Hillard EA Bioorg Med Chem Lett; 2011 Oct; 21(20):6195-7. PubMed ID: 21889342 [TBL] [Abstract][Full Text] [Related]
39. Toward novel HIV-1 integrase binding inhibitors: molecular modeling, synthesis, and biological studies. Mugnaini C; Rajamaki S; Tintori C; Corelli F; Massa S; Witvrouw M; Debyser Z; Veljkovic V; Botta M Bioorg Med Chem Lett; 2007 Oct; 17(19):5370-3. PubMed ID: 17716893 [TBL] [Abstract][Full Text] [Related]